Anonymous
Beloved of All
Dear Lord I ask for this safe, traditional, vaccine that actually PREVENTS covid-19 to be approved ASAP by the US FDA and be ok'd for boosters as well as it is in the rest of the world, in Jesus Name.
"GAITHERSBURG, Md. — The company filed for emergency use authorization with the Food and Drug Administration at the end of January.
More than two months later, there is still no answer from the FDA.
"It's been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it," said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
Gostin says another vaccine option is important for the U.S.
"The FDA should authorize it and it should be another vaccine in the toolbox for the United States and the world," he said.
In an interview with WUSA9 just days after filing for emergency use, a Novavax official told us, unlike Moderna and Pfizer's mRNA vaccines, many people are holding out for Novavax's protein-based shot, which is very similar to many childhood immunizations.
"We think that our vaccine can be an important option in making people feel more comfortable and confident in getting their vaccination," said Silvia Taylor with Novavax Global Corporate Affairs.
Clinical trials have proven this new vaccine to be 90% effective. If approved, those 18 years and older would be eligible for the shot. If approved, Gaithersburg, Maryland-based Novavax would be the fourth available vaccine in the United States."
"GAITHERSBURG, Md. — The company filed for emergency use authorization with the Food and Drug Administration at the end of January.
More than two months later, there is still no answer from the FDA.
"It's been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it," said Lawrence Gostin, a Professor of Global Health Law at Georgetown University.
Gostin says another vaccine option is important for the U.S.
"The FDA should authorize it and it should be another vaccine in the toolbox for the United States and the world," he said.
In an interview with WUSA9 just days after filing for emergency use, a Novavax official told us, unlike Moderna and Pfizer's mRNA vaccines, many people are holding out for Novavax's protein-based shot, which is very similar to many childhood immunizations.
"We think that our vaccine can be an important option in making people feel more comfortable and confident in getting their vaccination," said Silvia Taylor with Novavax Global Corporate Affairs.
Clinical trials have proven this new vaccine to be 90% effective. If approved, those 18 years and older would be eligible for the shot. If approved, Gaithersburg, Maryland-based Novavax would be the fourth available vaccine in the United States."
Novavax asked the FDA for emergency use earlier this year. What's the delay?
Novavax filed for emergency use for its COVID-19 vaccine with the FDA Jan. 31. Two months later, there is still no sign of a decision from regulators.
www.wusa9.com